Positive FDA Response on Preservative-Free Ketamine After President Trump Orders Accelerated Approval for Psychedelic Medication Developers Including NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

depression

Positive FDA Response on Preservative-Free Ketamine After President Trump Orders Accelerated Approval for Psychedelic Medication Developers Including NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

ONLY AVAILABLE IN PAID PLANS.

Originally reported by financialcontent. Read more

Source: https://www.financialcontent.com/article/getnews-2026-4-22-positive-fda-response-on-preservative-free-ketamine-after-president-trump-orders-accelerated-approval-for-psychedelic-medication-developers-including-nrx-pharmaceuticals-inc-nasdaq-nrxp